Global Amniotic Membrane Market Is Estimated To Hold A Value Of US$ 11.12 Bn In 2032

Application Of Amniotic Membrane In Surgical Wounds To Garner A Revenue Share Of 36%

In a recent market study, Fact.MR covers recent developments in the global amniotic membrane market, highlighting vital aspects such as trends, drivers, opportunities, and restraints. The report studies recent developments in the segments of the market in terms of product, application and end-use.

Fact.MR – A Market Research and Competitive Intelligence Provider: The global amniotic membrane market analysis is expected to carry a market value of US$ 11.12 Bn in 2032 and is expected to extend at a CAGR of 14% by 2032.

Growth in the scope of the amniotic membrane market can be associated to the increasing cases of accidents and the rising awareness about the benefits provided by the amniotic membrane.

The advantages performed by the amniotic membranes, such as their ability to decrease pain, this led to the growing adoption of tissue-based products to heal surgical wounds. Increasing expenditure in R&D in regenerative medicine and stem cells is expected to increase the scope of the market size by 2032.

For Critical Insights On This Market, Request For More Info

https://www.factmr.com/connectus/sample?flag=S&rep_id=7125

The global amniotic membrane market trend climbed at a CAGR of 12% from 2015 to 2021, procuring a market value of US$ 2 Bn. The market is expected to attain owing to the increasing population of glaucoma patients.

The global amniotic membrane market analysis is likely to hold a market value of US$ 11.12 Bn in 2032. The demand for advanced wound care is expected to rise the market value of amniotic membrane. The expansion of the market can be associated to the growing geriatric population, which has resulted in a rise in ophthalmology surgeries, assuming a compelling demand for these tissue-based products.

The outbreak of COVID-19 has given a negative impact on the market owing to the disruptions caused in the supply chain. Temporary halt in supply and manufacturing made the market low by restraining revenue generation. The key players are taking various initiatives to reverse the challenges posed by the COVID-19 lockdown.

Key Takeaways:

• The global amniotic membrane market analysis is expected to provide USD 3 Bn in 2022
• North America to acquire a revenue share of about 30% for amniotic membranes in 2032
• Europe to experience noteworthy growth, escalating at a CAGR of 10% through 2032
• By application, surgical damage to comprise 36% of the global market revenue
• Hospitals are primary end users, estimated to account for nearly 2/5th of the global market share

Growth drivers:

• The increasing pervasiveness of ocular disorders is expected to produce high demand for wound care techniques like amniotic membrane transplant, which is likely to extend the trend of the market by 2032.
• North America is expected to hold a significant market share by 2032 owing to the increasing demand for amniotic eye treatment. The region is likely to have secured a revenue share of about 30% in 2022.
• The growing demand for ophthalmology amniotic eye treatment in the U.S is expected to be a major cause aggregating the market size by 2032.

To learn more about the Global Amniotic Membrane Market, you can get in touch with our Analyst at

https://www.factmr.com/connectus/sample?flag=AE&rep_id=7125

Competitive Landscape:

• In December 2021, Audax Private Equity registered that it had successfully concluded the sale of Katena Products to Corza Medical. Corza Medical is a GTCR portfolio company. Katena is a globally acknowledged entity for offering ophthalmic devices and therapeutics to hospitals, surgical centers, and clinics.
• In July 2002, Merakris Therapeutics rolled out Dermacyte Matrix, which is an amniotic membrane used for the repair and protection of damaged tissues.
• In February 2022, TissueTech, released its plan of rebranding with a new name and a new logo. BioTissue, Inc and Amniox Medical, Inc. will both be known under a single entity called, BioTissue, Inc.

Key Players in the global amniotic membrane market include:

• Alliqua BioMedical Inc.
• Amnio Technology LLC
• Applied Biologics LLC
• Human Regenerative Technologies LLC
• DermaSciences
• Katena Products Inc.
• MiMedx Group Inc.
• Skye Biologics Inc.
• Amniox Medical Inc.
• Integra LifeSciences Corporation

More Valuable Insights on the Global Amniotic Membrane Market

Fact.MR provides an unbiased analysis of the global amniotic membrane market, presenting forecast statistics for the period from 2022-2032. The study divulges compelling insights on the global amniotic membrane market with a detailed segmentation on the basis of:

• By Product
  • Cryopreserved Amniotic Membrane
  • Dehydrated Amniotic Membrane
• By Application
  • Amniotic Membrane for Surgical Wounds
  • Amniotic Membrane for Ophthalmology
  • Amniotic Membrane for Other Applications
• By End Use
  • Amniotic Membrane for Hospitals
  • Amniotic Membrane for Ambulatory Surgical Centers
  • Amniotic Membrane for Specialty Clinics
  • Amniotic Membrane for Academic & Research Institutes

Key Questions Covered in Global Amniotic Membrane Market Report

• What was the amniotic membrane market value in 2021?
• What is the expected market value for amniotic membranes in 2022?
• At what percentage did the amniotic membrane industry flourish from 2015-2021?
• What is the expected forecast CAGR from 2022 to 2032 for amniotic membranes?
• What is the anticipated market value for amniotic membranes in 2032?
• How opportunistic is the market for amniotic membranes in North America?
• What growth prospects abound in Europe for amniotic membranes?
• Which application segment is expected to account for bulk of amniotic membrane sales?

Explore Fact.MR’s Coverage on the Healthcare Domain –

Immunoassay Market Analysis - The global immunoassays market is expected to grow at a rapid pace. For the diagnosis of infectious disorders, immunoassay analyzers such as enzyme-linked immunosorbent assay (ELISA), chemiluminescence immunoassay (CLIA), and immunofluorescence assay (IFA) are chosen.

PCR and Real-time PCR Molecular Diagnostics Market - The COVID-19 pandemic has boosted prospects for the growth of the PCR and real-time PCR molecular diagnostics market. Real-time (qPCR) and digital (dPCR) PCR tests have been used in a variety of healthcare settings to detect and diagnose potential cases

Rapid Medical Diagnostic Kits Market Forecast - Infectious disease incidence has been steadily increasing over the last few decades, driving up demand for rapid medical diagnostic kits around the world. The need to detect novel pathogens that cause diseases is propelling the market forward. The low cost of rapid medical diagnostic kits is propelling market growth.

Predictive Diagnostics Market Insights - Predictive diagnostics is one strategy that healthcare organizations can use to improve outcomes while lowering costs. The use of predictive diagnostics is predicted to revolutionize the way the healthcare industry works, thanks to improvements in data-based technology and their convergence with healthcare practices.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com

Source: Fact.MR